PBM Reform Bill Reducing Cost Sharing In Part D Clears Senate Panel Without Biosimilar Policies

 
• By Cathy Kelly
  
Bill Seeks PBM Reforms That Produce Savings At The Pharmacy Counter

More from Drug Pricing

More from Policy & Regulation